WallStreetZenWallStreetZen

NASDAQ: IOVA
Iovance Biotherapeutics Inc Stock Ownership - Who owns Iovance Biotherapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Iovance Biotherapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Raj K. PuriChief Regulatory Officer2025-03-142,509$3.59
$9.01kSell
Frederick G. VogtInterim CEO General Counsel2025-03-0395,413$4.04
$385.47kSell
Igor BilinskyChief Operating Officer2025-03-0333,302$4.04
$134.54kSell
Raj K. PuriChief Regulatory Officer2025-03-0319,984$4.04
$80.74kSell
Finckenstein Friedrich GrafChief Medical Officer2025-03-0333,470$4.04
$135.22kSell
Jeanmarc BelleminChief Financial Officer2025-03-0331,734$4.04
$128.21kSell
Frederick G. VogtInterim CEO General Counsel2025-01-149,955$5.89
$58.63kSell
Finckenstein Friedrich GrafChief Medical Officer2025-01-141,578$5.89
$9.29kSell
Igor BilinskyChief Operating Officer2025-01-141,578$5.89
$9.29kSell
Raj K. PuriChief Regulatory Officer2024-12-163,759$7.84
$29.47kSell

1 of 4

IOVA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IOVA insiders and whales buy or sell their stock.

IOVA Shareholders

What type of owners hold Iovance Biotherapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ayer Capital Management LP171.78%563,224,483$1.99BInsider
Paul L. Kessler126.74%415,566,430$1.47BInsider
Wayne P. Rothbaum8.56%28,067,333$99.36MInsider
Vanguard Group Inc8.40%27,534,340$97.47MInstitution
Mhr Fund Management LLC7.45%24,417,103$86.44MInstitution
Blackrock Inc7.16%23,476,035$83.11MInstitution
Perceptive Advisors LLC6.74%22,112,266$78.28MInstitution
Atlantic Hamilton6.39%20,960,016$74.20MInsider
David J. Voyticky5.79%18,981,082$67.19MInsider
Sanford Hillsberg4.12%13,500,000$47.79MInsider

1 of 3

IOVA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IOVA18.22%81.78%Net SellingNet Selling
GERN76.82%1.09%Net BuyingNet Buying
AUPH42.00%11.18%Net BuyingNet Buying
MDXG45.61%54.39%Net SellingNet Selling
SNDX91.75%8.25%Net SellingNet Selling
View Top Biotech Stocks

Iovance Biotherapeutics Stock Ownership FAQ

Who owns Iovance Biotherapeutics?

Iovance Biotherapeutics (NASDAQ: IOVA) is owned by 73.64% institutional shareholders, 330.57% Iovance Biotherapeutics insiders, and 0.00% retail investors. Ayer Capital Management LP is the largest individual Iovance Biotherapeutics shareholder, owning 563.22M shares representing 171.78% of the company. Ayer Capital Management LP's Iovance Biotherapeutics shares are currently valued at $1.99B.

If you're new to stock investing, here's how to buy Iovance Biotherapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.